This effectively destroys the molecule, rendering it useless for research
Shannon says based on the evidence BPC-157 cannot currently be recommended as a treatment option in regenerative and sports medicine for patients with tendon, muscle and ligament injuries
AOD9604, by contrast, is not FDAapproved as an obesity medication, and while safety data are reassuring, its use for weight loss remains offlabel with mixed evidence for effectiveness
Moreover, in a xenograft mammary 4T1 tumor model, it has been demonstrated that the concurrent administration of BAPN and the enzyme-responsive drug (NQO1-SN38), designed to target breast tumors with the topoisomerase I inhibitor SN38, results in a cooperative reduction in tumor growth [100]
Additionally, datasets for model development and external validation were very different, particularly for the models developed in BSGE and externally validated in MEDAL